A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case report
@article{APM65382, author = {Hao Zeng and Yujie Liu and Weiya Wang and Yuan Tang and Panwen Tian and Weimin Li}, title = {A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case report}, journal = {Annals of Palliative Medicine}, volume = {10}, number = {7}, year = {2021}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/65382} }